Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CENPVL2 (Centromere protein V like 2) is described in genome databases as a pseudogene or paralog with sequence similarity to Centromere protein V (CENP-V). It is not considered a canonical protein-coding gene nor has it been implicated as a therapeutic target, druggable entity, or disease biomarker. There is no published evidence of direct biological function, disease links, or drug interactions for CENPVL2. Its main relevance lies in sequence annotation and comparative genomics, not in functional cell biology or medicine[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein V like 2 (CENPVL2).